High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia. - Cortes,J.; Estey,E.; O'Brien,S.; Giles,F.; Shen,Y.; Koller,C.; Beran,M.; Thomas,D.; Keating,M.; Kantarjian,H. (Cancer, 2001)